BMI1 and non-small cell lung carcinoma: Another piece of evidence comes from a study by Chang et al. [2], who revealed that miR-145 is downregulated when BMI1 is overexpressed, which boosts Sp1 expression and accelerates EMT in pemetrexed-resistant NSCLC cells [2].